Corrigendum: Prevalence and outcomes of pancreatic enzymes elevation in patients with COVID-19: a meta-analysis and systematic review

Front Public Health. 2023 May 4:11:1201405. doi: 10.3389/fpubh.2023.1201405. eCollection 2023.

You Zhou^#^{1

2

3}, Yu-Tong Ge^#^{2

4}, Xiao-Xi Yang^{1

2}, Qian Cai¹, Yan-Bing Ding^{1

2}, Liang-Hao Hu⁵, Guo-Tao Lu^{1

2}

¹ Pancreatic Center, Department of Gastroenterology, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
² Yangzhou Key Laboratory of Pancreatic Disease, Institute of Digestive Diseases, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
³ Department of Nursing, Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, China.
⁴ Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
⁵ Department of Gastroenterology, Changhai Hospital, The Second Military Medical University, Shanghai, China.

^# Contributed equally.

Abstract

[This corrects the article DOI: 10.3389/fpubh.2022.865855.].

Keywords: COVID-19; elevation; meta-analysis; outcome; pancreatic enzymes; review.